Stay updated with breaking news from Oblte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Belite Bio, Inc (NASDAQ:BLTE – Get Rating) saw a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 31,700 shares, an increase of 13.6% from the March 31st total of 27,900 shares. Based on an average trading volume of 10,500 shares, the days-to-cover ratio is […]
Belite Bio, Inc (NASDAQ:BLTE – Get Rating) shares saw strong trading volume on Wednesday . 12,780 shares changed hands during mid-day trading, an increase of 27% from the previous session’s volume of 10,062 shares.The stock last traded at $29.75 and had previously closed at $29.87. Analysts Set New Price Targets A number of analysts have […]
Benchmark reissued their buy rating on shares of Belite Bio (NASDAQ:BLTE – Get Rating) in a research report report published on Tuesday, Benzinga reports. They currently have a $57.00 target price on the stock. Separately, HC Wainwright reiterated a buy rating and issued a $58.00 target price on shares of Belite Bio in a report […]
Belite Bio, Inc (NASDAQ:BLTE – Get Rating) gapped down before the market opened on Thursday . The stock had previously closed at $30.00, but opened at $28.85. Belite Bio shares last traded at $28.51, with a volume of 1,111 shares traded. Wall Street Analysts Forecast Growth A number of equities research analysts recently weighed in […]
Belite Bio (NASDAQ:BLTE – Get Rating)‘s stock had its “buy” rating reiterated by HC Wainwright in a research report issued to clients and investors on Tuesday, Benzinga reports. They presently have a $58.00 target price on the stock. HC Wainwright’s target price points to a potential upside of 100.28% from the company’s previous close. Separately, […]